66 filings
Page 3 of 4
8-K
dso2g0k9zs
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
8-K
9ku209 72bb9k
11 Feb 22
Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
11:00am
8-K
qv9mhpip3zyerbg2x
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
wk570 mxwr
17 Dec 21
Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
7:01am
8-K
f7sr829 h7xg2of4r
4 Nov 21
Passage Bio Reports Third Quarter 2021 Financial Results and Provides Recent Business Highlights
8:00am
8-K
8u2s23x4ngz77a
1 Nov 21
Departure of Directors or Certain Officers
5:01pm
8-K
zy7k4 2xntjdw
4 Oct 21
Regulation FD Disclosure
7:31am
8-K
v7opv0ackq mdnzgsto
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
8-K
ml6wipj6
21 Jul 21
Departure of Directors or Certain Officers
7:01am
8-K
on53umh47ks7hj20fx1
28 May 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
wdxrmw9
18 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
04eir
5 May 21
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
7:00am
8-K
h9ukjf
22 Mar 21
Departure of Directors or Certain Officers
7:00am
8-K
292c67qt4qkp68
3 Mar 21
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
7:01am
8-K
pschrlqzzf
19 Feb 21
Departure of Directors or Certain Officers
5:01pm
8-K
wp0ezaj9jnj5zr4cf
17 Feb 21
Departure of Directors or Certain Officers
5:00pm
8-K
v6jok
11 Jan 21
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
7:15am
8-K
5uhwlu4qd6famnlosf
18 Dec 20
Entry into a Material Definitive Agreement
7:00am
8-K
xrjhb r48ttqpcsk
10 Nov 20
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
7:00am
8-K
3k1nmrzk7l3cejf97m
9 Sep 20
Corporate Presentation SEPTEMBER 2020
7:00am